GA
ABBV icon

Greytown Advisors’s AbbVie ABBV Stock Holding History

Greytown Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,852
Closed -$337K – 72
2024
Q1 		$337K Sell
1,852
-501
-21% -$86.3K 0.19% 51
2023
Q4 		$365K Hold
2,353
– – 0.19% 52
2023
Q3 		$351K Sell
2,353
-2,089
-47% -$307K 0.19% 50
2023
Q2 		$598K Hold
4,442
– – 0.33% 39
2023
Q1 		$708K Sell
4,442
-91
-2% -$13.9K 0.37% 37
2022
Q4 		$733K Sell
4,533
-871
-16% -$134K 0.4% 35
2022
Q3 		$725K Sell
5,404
-820
-13% -$118K 0.44% 37
2022
Q2 		$953K Sell
6,224
-907
-13% -$139K 0.54% 30
2022
Q1 		$1.16M Sell
7,131
-4,067
-36% -$591K 0.56% 31
2021
Q4 		$1.52M Sell
11,198
-139
-1% -$16.4K 0.64% 27
2021
Q3 		$1.22M Sell
11,337
-758
-6% -$86.6K 0.54% 41
2021
Q2 		$1.36M Buy
12,095
+3,797
+46% +$428K 0.66% 23
2021
Q1 		$898K Buy
8,298
+464
+6% +$49.6K 0.45% 41
2020
Q4 		$839K Buy
7,834
+2,397
+44% +$230K 0.58% 26
2020
Q3 		$476K Sell
5,437
-954
-15% -$89.8K 0.39% 45
2020
Q2 		$627K Sell
6,391
-3,540
-36% -$312K 0.58% 25
2020
Q1 		$757K Sell
9,931
-2,247
-18% -$191K 0.75% 28
2019
Q4 		$1.08M Sell
12,178
-150
-1% -$12.5K 0.76% 25
2019
Q3 		$933K Buy
12,328
+1,439
+13% +$98.7K 0.69% 29
2019
Q2 		$792K Buy
+10,889
New +$856K 0.57% 42

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Greytown Advisors's ABBV Position: Q2 2024 in Review

Greytown Advisors sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 1,852 shares — an estimated $337K sold.

Greytown Advisors first reported a position in ABBV in Q2 2019 and held it in 20 quarters. The position peaked at $1.52M in Q4 2021. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Greytown Advisors reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Greytown Advisors sold 1,852 AbbVie shares in Q2 2024, an estimated $337K.
  • Greytown Advisors first reported a position in AbbVie in Q2 2019 and held it in 20 quarters.
  • Greytown Advisors's AbbVie position peaked at $1.52M in Q4 2021.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Greytown Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.